• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zydus Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Cadila
  • BSE Code : 20883.0
  • ISIN : INE010B01027
949.05 -21 (-2.14%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    946.35

  • Today’s High

    970.75

  • Open

    970.00

  • Perv Close

    969.80

  • 52W Low

    795.00

  • 52W High

    1,324.30

Key Indicators

  • P/E(TTM)

    16.61

  • Mar.Cap (₹Cr.)

    95,496.64

  • Div & Yield %

    1.16

  • Book Value(₹)

    210.59

  • Debt-Equity Ratio

    -2.14

  • AGM Date

    01-Aug-2025

  • EPS

    57.12

  • P/E Ratio

    16.61

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    95,496.64

  • RONW (%)

    20.64

  • ROCE (%)

    23.94

Score Board

  • Equity (₹ in Cr.)

    100.62

  • BV (₹)

    210.60

  • Sales( ₹ in Cr.)

    15,116.30

  • NP (in Cr.)

    5,747.50

  • NP Var(%)

    67.0

  • Div%

    1100.0

  • CPS (₹)

    62.30

  • EPS (₹)

    57.10

  • Traded Value (₹ in Lakhs)

    95,486.57

  • 52 Week High

    1,324.30

  • 52 Week Low

    795.00

  • Price BSE

    949.0

  • Price NSE

    949.00

  • Market Capital( in Cr.)

    95,486.57

  • P/C Ratio

    15.20

  • P/E Ratio

    16.60

  • Price Vs.BV

    57.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 15,116.30 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 15,116.30 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40
Other Income 696.20 1,084.80 548.40 178.70 89.30 908.70
Stock Adjustments 121.10 131.70 -105.10 46.90 148.30 -15.50
Total Income 15,933.60 12,035.20 9,174.90 8,062.50 8,017.60 7,240.60
EXPENDITURE :            
Raw Materials 3,138.00 3,284.60 3,066.20 2,917.10 2,499.70 1,936.20
Power and Fuel Cost 286.20 298.20 278.60 245.20 193.20 208.40
Employee Cost 1,762.20 1,507.50 1,321.90 1,204.90 1,147.30 1,077.40
Other Manufacturing Expenses 439.70 347.20 332.50 381.10 363.40 327.30
Selling and Administration Expenses 1,384.00 1,017.80 1,039.80 958.40 1,009.10 925.30
Miscellaneous Expenses 491.00 445.00 336.90 578.30 594.40 486.20
Employee Benefit Expenses 1,762.20 1,507.50 1,321.90 1,204.90 1,147.30 1,077.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,501.10 6,900.30 6,375.90 6,285.00 5,807.10 4,960.80
Operating Profit 8,432.50 5,134.90 2,799.00 1,777.50 2,210.50 2,279.80
Interest 463.90 390.70 278.20 134.90 70.90 233.90
Gross Profit 7,968.60 4,744.20 2,520.80 1,642.60 2,139.60 2,045.90
Depreciation 523.90 504.40 488.60 478.70 451.10 428.90
Profit Before Tax 7,444.70 4,239.80 2,032.20 1,163.90 1,688.50 1,617.00
Current Tax 1,582.50 934.30 461.80 260.20 303.30 164.10
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 87.30 -136.00 41.20 45.80 -91.00 40.00
Reported Net Profit 5,774.90 3,441.50 1,529.20 857.90 1,476.20 1,412.90
Extraordinary Items 27.40 3.90 -92.27 -237.64 -156.95 -52.67
Adjusted Net Profit 5,747.50 3,437.60 1,621.47 1,095.54 1,633.15 1,465.57
Adjustment below Net Profit -26.40 -54.00 1.80 -6.90 -15.30 -6.00
P & L Balance brought forward 13,347.60 10,567.40 9,289.40 8,796.90 7,336.00 6,645.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 301.90 607.30 253.00 358.50 0.00 716.60
P & L Balance carried down 18,794.20 13,347.60 10,567.40 9,289.40 8,796.90 7,336.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,100.00 300.00 600.00 250.00 350.00 350.00
Dividend Per Share(Rs) 11.00 3.00 6.00 2.50 3.50 3.50
Earnings Per Share-Unit Curr 57.40 34.21 15.11 8.38 14.42 13.80
Earnings Per Share(Adj)-Unit Curr 57.40 34.21 15.11 8.38 14.42 13.80
Book Value 210.64 156.23 134.78 129.30 124.46 109.96
Book Value(Adj)-Unit Curr 210.64 156.23 134.78 129.30 124.46 109.96

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,730 0.00 17,730 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 278,466 0.03 278,466 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 754,328,118 74.97 754,328,118 2
Others 0 0.00 0 0
Sub Total 754,624,314 74.99 754,624,314 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 15,785 0.00 15,785 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 20,594 0.00 18,284 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 71,766,504 7.13 71,766,504 632
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 53,211,946 5.29 53,211,946 15
Mutual Funds / UTI 55,940,674 5.56 55,940,674 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,851,761 0.28 2,851,761 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 183,807,264 18.27 183,804,954 697
2] Non Institution
Bodies Corporate 5,629,241 0.56 5,629,241 956
Clearing Members 1,186 0.00 1,186 10
Directors of their Relatives 372,464 0.04 372,464 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,045,371 0.30 3,038,546 8,302
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,509,310 0.15 1,508,560 4,400
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,629,237 0.76 7,629,237 7
Individuals holding nominal share capital up to Rs. 1 lakh 47,273,436 4.70 45,981,201 371,624
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 198,983 0.02 198,983 18
Others 1,689,379 0.17 1,689,379 2
Sub Total 67,802,412 6.74 66,502,602 385,418
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 1,006,233,990 100.00 1,004,931,870 386,127

Company Background

Zydus Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zydus Lifesciences Ltd
  • BSE Code : 20883.0
  • ISIN : INE010B01027

  • Incorporation Year

    1995

  • Registered Office

    Zydus Corporate Park S No 536
    Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad,
    Gujarat-382481

  • Telephone

    91-079-26868100

  • FAX

    91-079-26868337/26862365/26862366

  • Chairman

    Pankaj R Patel

  • Managing Director

    Sharvil P Patel

  • Company Secretary

    Dhaval N Soni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Zydus Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zydus Lifesci. 948.95 15,812.50 15,116.30 16.54 30.47
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10